251 related articles for article (PubMed ID: 28539357)
21. The roles of transmembrane 6 superfamily member 2 rs58542926 polymorphism in chronic liver disease: A meta-analysis of 24,147 subjects.
Chen X; Zhou P; De L; Li B; Su S
Mol Genet Genomic Med; 2019 Aug; 7(8):e824. PubMed ID: 31309745
[TBL] [Abstract][Full Text] [Related]
22. Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease.
Jiang ZG; Tapper EB; Kim M; Connelly MA; Krawczyk SA; Yee EU; Herman MA; Mukamal KJ; Lai M
J Clin Gastroenterol; 2018; 52(5):444-451. PubMed ID: 28362682
[TBL] [Abstract][Full Text] [Related]
23. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
[TBL] [Abstract][Full Text] [Related]
24. PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis.
Falleti E; Cussigh A; Cmet S; Fabris C; Toniutto P
Dig Liver Dis; 2016 Jan; 48(1):69-75. PubMed ID: 26493626
[TBL] [Abstract][Full Text] [Related]
25. Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice.
Fan Y; Lu H; Guo Y; Zhu T; Garcia-Barrio MT; Jiang Z; Willer CJ; Zhang J; Chen YE
Gastroenterology; 2016 May; 150(5):1208-1218. PubMed ID: 26774178
[TBL] [Abstract][Full Text] [Related]
26. Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism.
Liu J; Ginsberg HN; Reyes-Soffer G
Curr Opin Lipidol; 2024 Jun; 35(3):157-161. PubMed ID: 38465912
[TBL] [Abstract][Full Text] [Related]
27. The impact of transmembrane 6 superfamily 2 (TM6SF2) rs58542926 on liver-related events in patients with advanced chronic liver disease.
Balcar L; Scheiner B; Urheu M; Weinberger P; Paternostro R; Simbrunner B; Semmler G; Willheim C; Pinter M; Ferenci P; Trauner M; Reiberger T; Stättermayer AF; Mandorfer M
Dig Liver Dis; 2023 Aug; 55(8):1072-1080. PubMed ID: 36863929
[TBL] [Abstract][Full Text] [Related]
28. Association of PNPLA3 rs738409 and TM6SF2 rs58542926 with health services utilization in a population-based study.
Köpp J; Fleßa S; Lieb W; Markus MRP; Teumer A; Homuth G; Wallaschofski H; Marschall P; Völzke H; Baumeister SE
BMC Health Serv Res; 2016 Feb; 16():41. PubMed ID: 26847197
[TBL] [Abstract][Full Text] [Related]
29. Relationships among N,N-dimethylformamide exposure, CYP2E1 and TM6SF2 genes, and non-alcoholic fatty liver disease.
Zhou Z; Sang L; Wang J; Song L; Zhu L; Wang Y; Xiao J; Lian Y
Ecotoxicol Environ Saf; 2021 Nov; 228():112986. PubMed ID: 34794021
[TBL] [Abstract][Full Text] [Related]
30. TM6SF2-rs58542926 Genetic Variant Modifies the Protective Effect of a "Prudent" Dietary Pattern on Serum Triglyceride Levels.
Kalafati IP; Dimitriou M; Revenas K; Kokkinos A; Deloukas P; Dedoussis GV
Nutrients; 2023 Feb; 15(5):. PubMed ID: 36904112
[TBL] [Abstract][Full Text] [Related]
31. Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes.
Viktorinova A; Malickova D; Svitekova K; Choudhury S; Krizko M
Diabetes Res Clin Pract; 2021 Jun; 176():108858. PubMed ID: 34015391
[TBL] [Abstract][Full Text] [Related]
32. Variations in TM6SF2, PCSK9 and PCSK7 genes and risk of hepatic steatosis after liver transplantation: a cross-sectional study.
Eshraghian A; Moasser E; Azarpira N; Fattahi MR; Nikeghbalian S; Malek-Hosseini SA; Geramizadeh B
BMC Gastroenterol; 2021 Dec; 21(1):458. PubMed ID: 34876018
[TBL] [Abstract][Full Text] [Related]
33. Metabolic disorders induced by PNPLA3 and TM6SF2 gene variants affect chronic kidney disease in patients infected with non-genotype 3 hepatitis C virus.
Liu J; Qi W; Wang S; Zhang Y; Wang X; Sun D; Xu Y; Shi J; Duan H; Zhang Q; Wang H; Wang J
Lipids Health Dis; 2023 Jul; 22(1):91. PubMed ID: 37400794
[TBL] [Abstract][Full Text] [Related]
34. APOC3rs2854116, PNPLA3rs738409, and TM6SF2rs58542926 polymorphisms might influence predisposition of NAFLD: A meta-analysis.
Tong M; Wang F
IUBMB Life; 2020 Aug; 72(8):1757-1764. PubMed ID: 32525256
[TBL] [Abstract][Full Text] [Related]
35. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
Krawczyk M; Rau M; Schattenberg JM; Bantel H; Pathil A; Demir M; Kluwe J; Boettler T; Lammert F; Geier A;
J Lipid Res; 2017 Jan; 58(1):247-255. PubMed ID: 27836992
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
37. Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON.
Lorenzatti AJ; Monsalvo ML; López JAG; Wang H; Rosenson RS
Cardiovasc Diabetol; 2021 Apr; 20(1):94. PubMed ID: 33941192
[TBL] [Abstract][Full Text] [Related]
38. Influence of Type 2 Diabetes in the Association of
Gabriel-Medina P; Ferrer-Costa R; Rodriguez-Frias F; Ciudin A; Augustin S; Rivera-Esteban J; Pericàs JM; Selva DM
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625751
[TBL] [Abstract][Full Text] [Related]
39. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].
Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387
[No Abstract] [Full Text] [Related]
40. Liver-Specific Deletion of Mouse Tm6sf2 Promotes Steatosis, Fibrosis, and Hepatocellular Cancer.
Newberry EP; Hall Z; Xie Y; Molitor EA; Bayguinov PO; Strout GW; Fitzpatrick JAJ; Brunt EM; Griffin JL; Davidson NO
Hepatology; 2021 Sep; 74(3):1203-1219. PubMed ID: 33638902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
